Detalles de la búsqueda
1.
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine manufactured with and without polysorbate 80 given to healthy infants at 2, 3, 4 and 12 months of age.
Pediatr Infect Dis J
; 34(2): 180-5, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25126854
2.
NIHR Medicines for Children Research Network: improving children's health through clinical research.
Expert Rev Clin Pharmacol
; 6(5): 581-7, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24070097
3.
13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label trial.
Vaccine
; 31(9): 1284-92, 2013 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23306363
4.
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in India.
Pediatr Infect Dis J
; 32(5): 509-16, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23190777
5.
Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine.
Vaccine
; 29(16): 2947-55, 2011 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-21335032
Resultados
1 -
5
de 5
1
Próxima >
>>